Understanding fibrosis in eosinophilic esophagitis: Are we there yet?

Jennifer Armbruster-Lee, Cary P Cavender, Jay A Lieberman, Amali E Samarasinghe

Journal: Journal of leukocyte biology 2019;104(1):31-40

PMID: 29377264

Abstract

Eosinophilic esophagitis (EoE) is an immune/antigen-mediated, progressive fibrostenotic disease characterized by symptoms of esophageal dysfunction and abnormal eosinophilic infiltration in the esophagus. Despite current treatment modalities of dietary antigen elimination or topical corticosteroids, a subset of patients do not have clinical or histologic response. Even with resolution of superficial epithelial eosinophilia, patients may still have progressive subepithelial fibrosis, which may lead to esophageal strictures over time. Histologic identification of subepithelial fibrosis requires deep esophageal biopsies, which are not routinely obtained. Herein, we review the challenges in diagnosing and treating fibrosis in EoE. We propose the novel concept of vitamin D supplementation to treat fibrosis in EoE through downregulation of profibrotic mediator, transforming growth factor-beta.

©2018 Society for Leukocyte Biology.

Address: Department of Pediatrics, Division of Gastroenterology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.; Department of Pediatrics, Division of Allergy/Immunology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.; Department of Pediatrics, Division of Pulmonology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.; Children's Foundation Research Institute, Memphis, Tennessee, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.